BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 10369589)

  • 1. Immunohistochemical distinction of ocular sebaceous carcinoma from basal cell and squamous cell carcinoma.
    Sinard JH
    Arch Ophthalmol; 1999 Jun; 117(6):776-83. PubMed ID: 10369589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic utility of adipophilin immunostain in periocular carcinomas.
    Milman T; Schear MJ; Eagle RC
    Ophthalmology; 2014 Apr; 121(4):964-71. PubMed ID: 24290802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen receptor identification in the diagnosis of eyelid sebaceous carcinomas.
    Jakobiec FA; Werdich X
    Am J Ophthalmol; 2014 Mar; 157(3):687-96.e1-2. PubMed ID: 24333189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemistry in ocular carcinomas.
    Sramek B; Lisle A; Loy T
    J Cutan Pathol; 2008 Jul; 35(7):641-6. PubMed ID: 18201230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perforin expression in eyelid sebaceous carcinomas: a useful and specific immunomarker for the differential diagnosis of eyelid carcinomas.
    Mittal R; Araujo I; Czanner G; Coupland SE
    Acta Ophthalmol; 2016 Aug; 94(5):e325-30. PubMed ID: 26843360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sebaceous carcinoma: clinicopathologic features and diagnostic role of immunohistochemistry (including androgen receptor).
    Mulay K; White VA; Shah SJ; Honavar SG
    Can J Ophthalmol; 2014 Aug; 49(4):326-32. PubMed ID: 25103648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of D2-40 in benign and malignant sebaceous tumors and comparison to basal and squamous cell carcinomas.
    Yang HM; Cabral E; Dadras SS; Cassarino DS
    Am J Dermatopathol; 2008 Dec; 30(6):549-54. PubMed ID: 19033927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ber EP4 and epithelial membrane antigen aid distinction of basal cell, squamous cell and basosquamous carcinomas of the skin.
    Beer TW; Shepherd P; Theaker JM
    Histopathology; 2000 Sep; 37(3):218-23. PubMed ID: 10971697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative examination of androgen receptor reactivity for differential diagnosis of sebaceous carcinoma from squamous cell and basal cell carcinoma.
    Asadi-Amoli F; Khoshnevis F; Haeri H; Jahanzad I; Pazira R; Shahsiah R
    Am J Clin Pathol; 2010 Jul; 134(1):22-6. PubMed ID: 20551262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of immunohistochemistry in the diagnosis of sebaceous carcinoma: a clinicopathologic and immunohistochemical study.
    Plaza JA; Mackinnon A; Carrillo L; Prieto VG; Sangueza M; Suster S
    Am J Dermatopathol; 2015 Nov; 37(11):809-21. PubMed ID: 26485238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collision sebaceous and basal cell carcinomas of the eyelid.
    Levy J; Cagnano E; Benharroch D; Monos T; Lifshitz T
    Ann Diagn Pathol; 2006 Jun; 10(3):157-9. PubMed ID: 16730311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunohistochemical localization of MUC 1 and keratin 14 in the invasive regions of malignant eyelid tumors].
    Uehara F; Ohba N; Yonezawa S; Sato E
    Nippon Ganka Gakkai Zasshi; 1997 Nov; 101(11):866-73. PubMed ID: 9396233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunolabeling pattern of cytokeratin 19 expression may distinguish sebaceous tumors from basal cell carcinomas.
    Heyl J; Mehregan D
    J Cutan Pathol; 2008 Jan; 35(1):40-5. PubMed ID: 18095993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic use of low molecular weight keratin expression in sebaceous carcinoma.
    Murata T; Nakashima Y; Takeuchi M; Sueishi K; Inomata H
    Pathol Res Pract; 1993 Sep; 189(8):888-93. PubMed ID: 7508102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sebaceous gland carcinoma of the ocular adnexa - variability in clinical and histological appearance with analysis of immunohistochemical staining patterns.
    Schmitz EJ; Herwig-Carl MC; Holz FG; Loeffler KU
    Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2277-2285. PubMed ID: 28741159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical staining for adipophilin, perilipin and TIP47.
    Muthusamy K; Halbert G; Roberts F
    J Clin Pathol; 2006 Nov; 59(11):1166-70. PubMed ID: 16556662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical findings of sebaceous carcinoma and sebaceoma: retrieval of cytokeratin expression by a panel of anti-cytokeratin monoclonal antibodies.
    Ansai S; Arase S; Kawana S; Kimura T
    J Dermatol; 2011 Oct; 38(10):951-8. PubMed ID: 21592202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycopathological study of eyelid tumors and pseudotumors.
    Uehara F; Yonezawa S; Sato E; Ohba N
    Jpn J Ophthalmol; 1997; 41(6):362-9. PubMed ID: 9509302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical localization of epidermal growth factor receptor and epithelial antigen in tumors of the human conjunctiva, eyelid, lacrimal gland, and orbit.
    Kodama T; Hayasaka S; Setogawa T
    Graefes Arch Clin Exp Ophthalmol; 1995 Nov; 233(11):672-6. PubMed ID: 8566822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal cell, squamous cell, and sebaceous gland carcinomas of the periorbital region.
    Lober CW; Fenske NA
    J Am Acad Dermatol; 1991 Oct; 25(4):685-90. PubMed ID: 1791226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.